M&A / Acquisition · MENA · Announced 27 Apr 2026
Pfizer → Jamjoom Pharma
M&A / Acquisition deal between Pfizer (Saudi Arabia) and Jamjoom Pharma (Saudi Arabia), covering Oral solid dosage, announced 27 Apr 2026. Value: Undisclosed.
Parties: PFIZER INC. (Saudi Arabia) → JAMJOOM PHARMACEUTICALS CO. (Saudi Arabia)
- Deal type
- M&A / Acquisition
- Value
- Undisclosed
- Territory
- Saudi Arabia
- Asset
- Oral solid dosage (OSD) manufacturing & packaging facility in King Abdullah Economic City (KAEC), Saudi Arabia. Full production chain (formulation → packaging) with on-site QC laboratories. Built and opened by Pfizer in 2017 at a ~$50M (SAR 187.5M) investment. (No specific product lines confirmed as part of the transfer.)
- Announced
- 27 Apr 2026
Our analysis
Why this matters.
Jamjoom Pharma — one of Saudi Arabia's largest generics manufacturers and a Tadawul-listed company (SAR 1.3bn revenue in 2024, up nearly 20%) — is acquiring the King Abdullah Economic City plant that Pfizer built in 2017 as a roughly $50m Vision 2030 localisation showcase.
The full analysis is free to read with a work email on this page.
Source: Zawya